Status:
COMPLETED
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Lupus Erythematosus
Eligibility:
All Genders
18-75 years
Brief Summary
The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatm...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age \>18 years
- Patient with systemic lupus erythematosus
- Treatment with PLAQUENIL for \> 6 months with dosage of hydroxychloroquinemia planned during the consultation.
Exclusion
Key Trial Info
Start Date :
November 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 16 2024
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06161363
Start Date
November 27 2023
End Date
December 16 2024
Last Update
December 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toulouse Hospital
Toulouse, France